Ad is loading...
MENU

CLBT Stock Tickeron detected bullish Stock Pattern: Broadening Wedge Ascending CLBT on November 06, 2024, netting in a 6.86% gain over 3 weeks

A.I.dvisor
at Tickeron.com
Loading...
+6.86% Gain from a Successful pattern Broadening Wedge Ascending
CLBT - Cellebrite DI Ltd
Tickeron
Ticker: CLBT
Company: Cellebrite DI
Gain: +6.86%
Confirmed: 11/06/24
Succeeded: 12/03/24
Total length: 27 days
On November 06, 2024, A.I.dvisor detected a Broadening Wedge Ascending Pattern (Bullish) for Cellebrite DI Ltd (CLBT, $19.09). On November 06, 2024, A.I.dvisor confirmed the Bullish pattern, setting a target price of $20.44. 27 days later, on December 03, 2024, CLBT reached the target price resulting in a for traders who took a long position in the stock.

CLBT's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CLBT turned positive on November 21, 2024. Looking at past instances where CLBT's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 21, 2024. You may want to consider a long position or call options on CLBT as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

CLBT moved above its 50-day moving average on November 19, 2024 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CLBT advanced for three days, in of 225 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 193 cases where CLBT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLBT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CLBT broke above its upper Bollinger Band on November 21, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CLBT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (66.225) is normal, around the industry mean (30.859). P/E Ratio (67.114) is within average values for comparable stocks, (159.968). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.755). Dividend Yield (0.000) settles around the average of (0.084) among similar stocks. P/S Ratio (6.435) is also within normal values, averaging (57.731).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

View a ticker or compare two or three
CLBT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry PackagedSoftware

Profile
Fundamentals
Details
Industry
N/A
Address
94 Shlomo Shmelzer Road
Phone
+972 733948000
Employees
1008
Web
https://www.cellebrite.com